PRG Science & Technology

CompanySouth KoreaFounded 2017RORWikidata

PRG Science & Technology develops one asset, in phase 2 (progerinin in progeria). Mostly small molecule acting on LMNA, proteostasis and cellular senescence; based in South Korea, founded in 2017.

Assets
1
Furthest
Phase 2
Trials
2
Signals
0

Pipeline

1

  • progerinin

    Inhibitor of progerin-lamin A interaction and binder of progerin to promote its clearance

    Phase 2Small moleculeLMNAProteostasisprogeriaWerner syndrome

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Evidence behind the mechanisms3
  • Trials2
  • Similar companies6

Updated 8 Oct 2026 · 6 sources

Intelligence